De-extinction startup Colossal Biosciences is in talks to raise new capital at a valuation between $20 billion and $30 billion, potentially doubling or tripling its previous valuation.
The funding round would represent significant growth for the biotech firm, which uses genetic engineering and synthetic biology to resurrect extinct species. Colossal has previously focused on reviving woolly mammoths and Tasmanian tigers through advanced biotechnology.
The reported valuation increase reflects growing investor interest in de-extinction and synthetic biology sectors. Colossal has secured previous funding from notable backers, including venture capital firms and tech entrepreneurs.
The company's technology aims to restore extinct species by editing the genomes of living relatives. If successful, the approach could have applications beyond de-extinction, including conservation efforts for endangered species and development of disease-resistant organisms.
Details on the timing of the funding round and lead investors have not been disclosed. The startup continues to advance its core projects while exploring the commercial and scientific potential of its platform.
Thinking Machines Lab, founded by former OpenAI CTO Mira Murati, is raising at least $1 billion at a $40 billion+ pre-money valuation—down from the $50 billion+ it targeted last year.
Qualcomm has invested in smart ring maker Ultrahuman as the company builds a new device powered by Qualcomm chips. Ultrahuman targets $200 million in annual revenue by January 2027.
Munich-based Atira secured $15 million in Series A funding led by Accel to scale its AI platform for automating complex bid proposal parsing and generation. The startup previously raised $2.5 million in pre-seed funding.
Autonomous trucking startup PlusAI plans to merge with blank-check firm Texas Ventures Acquisition III Corp, valuing the company at $800M pre-money. The move comes as PlusAI operates self-driving freight routes in Texas with logistics company Ryder.